STEALTHSTATION S7 / I7 / FUSION NAVIGATION SYSTEMS, AXIEM NAVIGATION SYSTEM
Device Facts
| Record ID | K133444 |
|---|---|
| Device Name | STEALTHSTATION S7 / I7 / FUSION NAVIGATION SYSTEMS, AXIEM NAVIGATION SYSTEM |
| Applicant | Medtronic Navigation, Inc. |
| Product Code | HAW · Neurology |
| Decision Date | Jul 25, 2014 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 882.4560 |
| Device Class | Class 2 |
Indications for Use
The StealthStation® System is intended as an aid for precisely locating anatomical structures in either open or percutaneous procedures. The StealthStation® System is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT-based or MR-based model, fluoroscopy images, or digitized landmarks of the anatomy.
Device Story
StealthStation System provides real-time surgical navigation; uses radiological patient images (CT/MR/fluoroscopy) to create translation map between patient anatomy and images. Surgeon uses system to plan/simulate surgical trajectories and create 2D/3D anatomical models. During surgery, system tracks specialized instruments via optical or electromagnetic sensors; continuously updates instrument position on images. Used in OR by surgeons to guide planning and approach; improves precision in locating anatomical structures. System includes hardware (digitizer/localizer, computer, reference frames) and software (operating system for resource management/data processing). Output displayed to surgeon to assist in clinical decision-making during procedures.
Clinical Evidence
Bench testing only. Verification and regression testing performed to confirm functionality and compatibility of the new operating system. No clinical data provided.
Technological Characteristics
Stereotaxic instrument; optical (infra-red) or electromagnetic tracking; hardware includes digitizer/localizer, computer, and reference frames. Software runs on Debian Linux operating system. Connectivity via standard computing hardware interfaces.
Indications for Use
Indicated for patients requiring stereotactic surgery where anatomical structures (skull, long bone, vertebra) can be referenced against CT, MR, fluoroscopy, or digitized landmarks. Applicable for open or percutaneous procedures.
Regulatory Classification
Identification
A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.
Predicate Devices
- StealthStation® System Update (K050438)
Submission Summary (Full Text)
{0}------------------------------------------------
# 510(k) Summary
# January 2, 2014
# K133444 JUL 2 5 2014
- I. Company: Medtronic Navigation, Inc. 826 Coal Creek Circle Louisville, Colorado 80027 USA Telephone Number: 720-890-3200 Fax Number: 720-890-3500
- Contact: Kaye Waite Regulatory Affairs Specialist Telephone Number: 720-890-2182 Fax Number: 720-890-3709
- Proprietary Trade Name: StealthStation® System II.
- III. Common Name: Stereotaxic Instrument
- Classification Name: Stereotaxic Instrument (21 CFR 882.4560) IV.
- V. Classification: Class II (21 CFR 882.4560)
- VI. Product Code: HAW, OLO
#### VII. Product Description:
The StealthStation® System includes hardware and software that enables realtime surgical navigation using radiological patient images. The navigation system creates a translation map between points in the patient anatomy and the corresponding points on radiologic images of the patient. Once this map is established (through a process called registration), the software can display the relative position of a tracked instrument to a representation of the patient's anatomy. In this way the images can help guide the surgeon's planning and approach. Prior to operating, the surgeon may then create, store, and simulate progression along one or more surgical trajectories. As an aid to visualization, the surgeon may also create and manipulate one or more 2D or 3D models of the anatomy. During surgery, the system tracks the position of specialized surgical instruments in or on the patient anatomy and continuously updates the instrument position on these images either by optical tracking or electromagnetic tracking.
The operating system is software that controls the execution of programs, and that provides services such as resource allocation, scheduling, input/output control, and data management. This includes managing computer system hardware and software resources and providing a common set of services for software applications to interface with computing hardware.
{1}------------------------------------------------
#### VIII. Indications for Use:
The StealthStation® System is intended as an aid for precisely locating anatomical structures in either open or percutaneous procedures. The StealthStation® System is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT-based or MR-based model, fluoroscopy images, or digitized landmarks of the anatomy.
#### IX. Identification of Legally Marketing Devices (Predicate Devices)
- StealthStation® System Update (K050438) .
#### X. Comparison of the Technological Characteristics:
The subject of this 510(k) is the StealthStation® System with an off-the-shelf operating system, which represents a minor modification to the StealthStation® System predicate device (K050438). The difference between the predicate and the subject device is the change to the operating system from proprietary to off-the-shelf. No changes have been made to the StealthStation® operating principle or hardware due to the change to the operating system.
| Item | Subject Devices | Predicate Devices |
|------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use | The StealthStation® System is intended as<br>an aid for precisely locating anatomical<br>structures in either open or percutaneous<br>procedures. The StealthStation® System is<br>indicated for any medical condition in<br>which the use of stereotactic surgery may<br>be appropriate, and where reference to a<br>rigid anatomical structure, such as the<br>skull, a long bone, or vertebra, can be<br>identified relative to a CT or MR based<br>model, fluoroscopy images, or digitized<br>landmarks of the anatomy. | StealthStation System Update - K050438<br>The StealthStation® System is intended as an<br>aid for precisely locating anatomical<br>structures in either open or percutaneous<br>procedures. The StealthStation® System is<br>indicated for any medical condition in which<br>the use of stereotactic surgery may be<br>appropriate, and where reference to a rigid<br>anatomical structure, such as the skull, a long<br>bone, or vertebra, can be identified relative to<br>a CT or MR based model, fluoroscopy<br>images, or digitized landmarks of the<br>anatomy.<br>Includes a list of clinical procedures. |
| Operating Principle<br>(Tracking Method) | Identical | StealthStation System Update - K050438<br>Optical (infra-red)<br>EM |
| Control Mechanism<br>(Hardware) | Identical | StealthStation System Update - K050438<br>Digitizer/Localizer<br>Computer<br>Reference Frames |
{2}------------------------------------------------
| System Accuracy | Identical | StealthStation System Update - K050438<br>Stand-alone accuracy was reported in<br>K050438 and will not change with the update<br>to the operating system. |
|------------------|--------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| Operating System | Debian Linux | StealthStation System Update - K050438<br>Linux (GemOS) |
.. The subject devices have the same intended use and technological characteristics as the predicate devices.
#### XI. Discussion of the Performance Testing
Testing was completed to ensure the functionality and compatibility with the identified Medtronic products. The following table summarizes the performance testing completed:
| Test | Description | Result |
|------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| Verification<br>(Functional) | Provides confirmation that the design and implementation of the operating system and all operating system infrastructure correctly fulfills all product requirements | Verification successful, operating system fulfills all product requirements |
| | Verification<br>(Regression) | Provides confidence that after a change to a product, unchanged but vulnerable portions of the product have not been adversely affected. |
| Validation | | Ensures that the product meets the needs of the end user. |
All tests passed, which demonstrates that the performance of the subject operating system is equivalent to that of the predicate device.
#### XII. Conclusions
The StealthStation® System with the Debian operating system has been shown through comparison and testing to be substantially equivalent to the identified predicate devices.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 25, 2014
Medtronic Navigation. Inc. Ms. Kaye Waite Senior Regulatory Affairs Specialist 826 Coal Creek Circle Louisville, CO 80027
Re: K133444
> Trade/Device Name: StealthStation® System Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: HAW, OLO Dated: June 26, 2014 Received: June 27, 2014
Dear Ms. Waite:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
{4}------------------------------------------------
Page 2 - Ms. Kaye Waite
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.goy/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Carlos L. Pena -S
Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
## DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
## Indications for Use
Form Approved: OMB No, 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
510(k) Number (if known) K133444
Device Name StealthStation System
## Indications for Use (Describe)
The StealthStation System is intended as an aid for precisely locating an either open or perculancous procedures. The SteathStation System is indical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as long bone, or vertebra, can be identified relative to a CT-hased model, fluoroscopy images, or digitized landmarks of the anatomy,
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
### FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
# Carlos L. Pena -S
This section applies only to requirements of the Paperwork Reduction Act of 1995.
### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and mainlain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
